Bharat Biotech to Submit Additional Data for Covid-19 Vaccine’s Emergency Approval

COVAXIN, an inactivated vaccine candidate, is currently undergoing Phase III human clinical trials on 26,000 volunteers at 25 centres across India, after having undergone Phase I and II trials involving 1,000 volunteers.

Leave a Reply

Your email address will not be published. Required fields are marked *